Concepedia

Author

Holly Bazmi

University of Pittsburgh

Also Known As

H Z Bazmi, Holly Bazmi, Holly Z. Bazmi

9

Publications

2.1K

Citations

8

H-Index

17

Concepts

All Affiliations

University of PittsburghNational Institute of Allergy and Infectious DiseasesEmory UniversityVeterans Health AdministrationUniversity of Pittsburgh Medical Center
HB

About

Holly Bazmi is an author at University of Pittsburgh specializing in drug resistance, medicine, and hiv.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

478

2

Natural Sciences

2

2

111

3

Biochemistry

2

2

111

4

Immunology

1

1

367

5

Molecular Biology

1

1

66

Holly Bazmi

×

8

Publications

2.1K

Citations

8

H-Index

YearCitations

New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma

Sarah Palmer, Ann Wiegand, Frank Maldarelli,

Journal of Clinical Microbiology

2003

608

Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis

Sarah Palmer, Mary F. Kearney, Frank Maldarelli,

Journal of Clinical Microbiology

2005

503

Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides

Raymond F. Schinazi, Robert M. Lloyd, M. Hong Nguyen,

Antimicrobial Agents and Chemotherapy

1993

367

Natural History of Human Immunodeficiency Virus Type 1 Viremia after Seroconversion and Proximal to AIDS in a Large Cohort of Homosexual Men

Robert H. Lyles, Álvaro Muñoz, Traci E. Yamashita,

The Journal of Infectious Diseases

2000

356

In Vitro Selection of Mutations in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase That Decrease Susceptibility to (−)-β- <scp>d</scp> -Dioxolane-Guanosine and Suppress Resistance to 3′-Azido-3′-Deoxythymidine

Holly Bazmi, Jennifer Hammond, Sócrates C.H. Cavalcanti,

Antimicrobial Agents and Chemotherapy

2000

99

Relationship between 3′-Azido-3′-Deoxythymidine Resistance and Primer Unblocking Activity in Foscarnet-Resistant Mutants of Human Immunodeficiency Virus Type 1 Reverse Transcriptase

Peter R. Meyer, S. Matsuura, Dianna L. Zonarich,

Journal of Virology

2003

66

DPC 817: a Cytidine Nucleoside Analog with Activity against Zidovudine- and Lamivudine-Resistant Viral Variants

Raymond F. Schinazi, John W. Mellors, Holly Bazmi,

Antimicrobial Agents and Chemotherapy

2002

48

Alkylglycerol Prodrugs of Phosphonoformate Are Potent In Vitro Inhibitors of Nucleoside-Resistant Human Immunodeficiency Virus Type 1 and Select for Resistance Mutations That Suppress Zidovudine Resistance

Jennifer Hammond, Dianna Koontz, Holly Bazmi,

Antimicrobial Agents and Chemotherapy

2001

45

Page 1